New Stent Retriever Technology Versus Standard Devices for Anterior Large Vessel Thrombectomy: A Multicenter Study
Por:
Puig, J, Dolz, G, Werner, M, Daunis-i-Estadella, P, Comas-Cufí, M, Tomasello, A, González, E, del Caño, XM, Vega, P, Murias, E, Bravo, I, Jiménez, E, Aparici-Robles, F, Sanchís, JM, Remollo, S, Castaño, C, Moreu, M, López-Frías, A, Terceño, M, Silva, Y, Chirife, O, López-Rueda, A, Martínez-Fernández, J, Méndez, JC, Sagredo, A, Díaz-Pérez, J, Cuba, V, Llibre, JC, Aguilar, Y, SanRoman, L and Blasco, J
Publicada:
1 nov 2025
Resumen:
Background and Purpose: Guidelines recommend stent retrievers (SRs) for treating large vessel occlusion (LVO) stroke. We assessed noninferiority of the iNtercept (iVascular) SR with a self-expanding basket on a pusher wire versus contemporary SRs (CSRs) using propensity score (PS) matching analysis. Methods: We analyzed data from the ROSSETTI multicenter registry of patients with anterior circulation LVO to compare procedural (recanalization rates according to the modified Thrombolysis In Cerebral Infarction (mTICI) score and procedural complications), clinical (modified Rankin Scale at 90 days), and safety (symptomatic intracranial hemorrhage, mortality at 90 days) outcomes of patients treated with iNtercept or CSRs (Solitaire, Trevo, and EmboTrap) as a first-line strategy, with or without balloon-guide catheter (BGC + SR, BCG - SR) after PS matching. Non-inferiority of iNtercept was established if the prespecified lower bound of the 95% confidence interval was over -10%. Results: A total of 164 and 132 patients treated first-line by iNtercept were matched to 656 and 132 patients treated first-line by CSR + BGC and CSR - BGC, respectively. After matching, successful reperfusion (mTICI2b/3) after first-line strategy was achieved in 53.7% and 54.8% in the iNtercept versus CSR + BGC groups, respectively (absolute difference, -0.1%), and 53.8% and 51.3% in the iNtercept versus CSR - BGC, respectively (2.6%). Final reperfusion rates and favorable 90-day outcomes were similar. iNtercept had fewer sICH, procedural complications, and emboli in a new territory than CSR + BGC, and fewer procedural complications than CSR - BGC. Conclusions: This multicenter registry with PS matching demonstrated the non-inferiority of iNtercept to approved CSRs for successful reperfusion in LVO acute ischemic stroke.
Filiaciones:
Puig, J:
Hosp Clin Barcelona, Radiol Dept CDI, Barcelona, Spain
IDIBAPS, Barcelona, Spain
Dolz, G:
Hosp Clin Barcelona, Neurointervent Dept CDI, Barcelona, Spain
Werner, M:
Hosp Clin Barcelona, Neurointervent Dept CDI, Barcelona, Spain
Daunis-i-Estadella, P:
Univ Girona, Dept Comp Sci Appl Math & Stat, Girona, Spain
Comas-Cufí, M:
Univ Girona, Dept Comp Sci Appl Math & Stat, Girona, Spain
Tomasello, A:
Vall Dhebron Univ Hosp, Intervent Neuroradiol, Barcelona, Spain
González, E:
Hosp Cruces, Intervent Neuroradiol, Radiol, Bilbao, Spain
del Caño, XM:
Hosp Cruces, Intervent Neuroradiol, Radiol, Bilbao, Spain
Vega, P:
Hosp Univ Cent Asturias, Radiol, Oviedo, Asturias, Spain
Murias, E:
Hosp Univ Cent Asturias, Radiol, Oviedo, Asturias, Spain
Bravo, I:
Hosp Reina Sofia, Diagnost & Therapeut Neuroradiol Unit, Cordoba, Spain
Jiménez, E:
Hosp Reina Sofia, Diagnost & Therapeut Neuroradiol Unit, Cordoba, Spain
Aparici-Robles, F:
Hosp Univ La Fe, Intervent Radiol, Valencia, Spain
Sanchís, JM:
Hosp Univ La Fe, Intervent Radiol, Valencia, Spain
:
Hosp Univ Germans Trias i Pujol, Dept Intervent Neuroradiol, Badalona, Spain
:
Hosp Univ Germans Trias i Pujol, Dept Intervent Neuroradiol, Badalona, Spain
Moreu, M:
Hosp Clin Univ San Carlos, Neurointervent Unit, Madrid, Spain
López-Frías, A:
Hosp Clin Univ San Carlos, Neurointervent Unit, Madrid, Spain
Terceño, M:
Hosp Univ Girona Doctor Josep Trueta, Dept Neurol, Stroke Unit, Girona, Spain
Silva, Y:
Hosp Univ Girona Doctor Josep Trueta, Dept Neurol, Stroke Unit, Girona, Spain
Chirife, O:
Hosp Univ Bellvitge, Neuroradiol, Barcelona, Spain
López-Rueda, A:
Hosp Univ Bellvitge, Neuroradiol, Barcelona, Spain
Martínez-Fernández, J:
Hosp Clin Univ, Neuroradiol, Santiago De Compostela, Spain
Méndez, JC:
Hosp Ramon & Cajal, Intervent Neuroradiol Unit, Radiol, Madrid, Spain
Sagredo, A:
Hosp Gen Univ Alicante, Intervent Neuroradiol, Valencia, Spain
Díaz-Pérez, J:
Hosp Clin Univ Virgen La Arrixaca, Intervent Neuroradiol, Murcia, Spain
Cuba, V:
Hosp Univ Tarragona Juan XXIII, Dept Radiol, Tarragona, Spain
Llibre, JC:
Hosp Clin Univ Salamanca, Dept Intervent Neuroradiol, Salamanca, Spain
Aguilar, Y:
Hosp Univ Insular Gran Canaria, Radiol Dept, Las Palmas Gran Canaria, Spain
SanRoman, L:
Hosp Clin Barcelona, Neurointervent Dept CDI, Barcelona, Spain
Blasco, J:
Hosp Clin Barcelona, Neurointervent Dept CDI, Barcelona, Spain
Green Submitted, hybrid
|